Passage Bio Inc
PASG
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.51M
Close$
$7.03
17.7% upside
Current Fair Value
17.7% upsideUndervalued by 17.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18.51 Million |
|---|---|
| Enterprise Value | $-9,071,936.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.35 |
| Beta | 1.38 |
| Outstanding Shares | 3,205,866 |
Return
| Return on Equity | -320.59% |
|---|---|
| Return on Assets | -103.33% |
| Return on Invested Capital | -255.10% |
Valuation & Multiples
| P/E Ratio | -0.49 |
|---|---|
| PEG | 0.96 |
| Price to Sales | - |
| Price to Book Ratio | 1.99 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.22 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.63 |
| Debt to Equity | 0.49 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$-2.31
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$-2.44
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 56.10%▲ 6.32% |
|---|---|
| Total Invested | $13.83M▼ 25.69% |
| Investors Holding | 33▲ 4.00% |
ESG Score
No data